Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2-/ERBB2-Altered Advanced Biliary Tract Cancers

被引：0
|
作者：
Zeme, Emily L. [1 ]
Van Loon, Katherine [1 ,2 ]
Kelley, Robin K. [1 ,2 ]
Gordan, John D. [1 ,2 ]
机构：
[1] Univ Calif San Francisco UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[2] UCSF, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 27期
关键词：
METASTATIC BREAST-CANCER; TRASTUZUMAB; PLACEBO; FOLFOX;
D O I：
10.1200/JCO.24.00868
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.
引用
收藏
页数：8
相关论文
共 50 条
  • [41] Relationship between CT characteristics and human epidermal growth factor receptor 2 expression in gastric cancers
    Chang Liu
    Feng Li
    Hong-Wei Zheng
    Qiu-Xia Feng
    Xi-Sheng Liu
    Liang Qi
    Yu-Dong Zhang
    Chinese Journal of Academic Radiology, 2020, 3 : 137 - 142
  • [42] Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers
    Thor, AD
    Edgerton, SM
    Liu, SQ
    Moore, DH
    Kwiatkowski, DJ
    CLINICAL CANCER RESEARCH, 2001, 7 (08) : 2415 - 2424
  • [43] An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer
    Elshazly, Ahmed M.
    Gewirtz, David A.
    CANCER DRUG RESISTANCE, 2022, 5 (02) : 472 - 486
  • [44] An observational cohort study of human epidermal growth factor receptor 2 (HER 2) over expression in oesophageal cancers
    Al-Momani, H.
    Barnes, R.
    Shah, R.
    Lewis, W.
    Edwards, P.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 90 - 90
  • [45] Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers
    Ilenia Migliaccio
    Luca Malorni
    Christopher D Hart
    Cristina Guarducci
    Angelo Di Leo
    BMC Medicine, 13
  • [46] Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers
    Migliaccio, Ilenia
    Malorni, Luca
    Hart, Christopher D.
    Guarducci, Cristina
    Di Leo, Angelo
    BMC MEDICINE, 2015, 13
  • [47] Concomitant Analysis of the Epidermal Growth Factor Receptor Family in Esophageal Cancer: Overexpression of Epidermal Growth Factor Receptor mRNA but Not of c-erbB-2 and c-erbB-3
    Helmut Friess
    Akira Fukuda
    Wen-Hao Tang
    Adrian Eichenberger
    Neva Furlan
    Arthur Zimmermann
    Murray Korc
    Markus W. Büchler
    World Journal of Surgery, 1999, 23 : 1010 - 1018
  • [48] Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer:: Overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3
    Friess, H
    Fukuda, A
    Tang, WH
    Eichenberger, A
    Furlan, N
    Zimmermann, A
    Korc, M
    Büchler, MW
    WORLD JOURNAL OF SURGERY, 1999, 23 (10) : 1010 - 1018
  • [49] Human epidermal growth factor receptor 2 testing recommendation
    Raji, Adekunle
    Lurie, Robert H.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2007, 131 (09) : 1330 - 1331
  • [50] Expression of Human Epidermal Growth Factor Receptor 2 in Meningiomas
    Ramezani, Mazaher
    Firoozabadi, Hanieh
    Rezaei, Mansour
    Khazaei, Sedigheh
    Sadeghi, Masoud
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (01) : 15 - 18
12345